About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD45.13
- USD45.23
- USD42.94
- USD45.48
- 35.50%
- 127M
- 5.47M
- 2.87M
- 8.5B
- 21.72
- 78.00%
Stock News
3 hours ago
DRC Medicine Ltd. Announces the Business Combination Agreement with Ribbon Acquisition Corp.
Yahoo
yesterday
Jim Cramer explains how younger buyers are driving market action
CNBC
yesterday
Despite tariffs, Andy Jassy says Amazon hasn't 'seen prices appreciably go up,' so far
CNBC
yesterday
Cristiano Ronaldo’s new $700 million contract reportedly includes private-jet credits and personal staff. Here’s how that compares with perks for other top athletes and CEOs.
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
